Overview
Jean-philippe Merlio practices practicing medicine in Bordeaux, France.
Mr. Merlio is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.
He is actively involved in clinical research, co-authoring 86 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Bordeaux, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Jean-philippe P. Merlio
Is Jean-philippe P. Merlio a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jean-philippe P. Merlio is classified as an Advanced expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jean-philippe P. Merlio participate in research or clinical trials?
Yes. Jean-philippe P. Merlio has published 86 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Jean-philippe P. Merlio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Anaplastic Large Cell LymphomaMr. Merlio isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaMr. Merlio isAdvanced. Learn about B-Cell Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Merlio isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaMr. Merlio isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Sezary SyndromeMr. Merlio isAdvanced. Learn about Sezary Syndrome.
- T-Cell LymphomaMr. Merlio isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Angioimmunoblastic T-cell LymphomaMr. Merlio isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- EGFR Positive Lung CancerMr. Merlio isExperienced. Learn about EGFR Positive Lung Cancer.
- ErythrodermaMr. Merlio isExperienced. Learn about Erythroderma.
- Exfoliative DermatitisMr. Merlio isExperienced. Learn about Exfoliative Dermatitis.
- Follicular LymphomaMr. Merlio isExperienced. Learn about Follicular Lymphoma.
- Giant Congenital Melanocytic NevusMr. Merlio isExperienced. Learn about Giant Congenital Melanocytic Nevus.
- Langerhans Cell HistiocytosisMr. Merlio isExperienced. Learn about Langerhans Cell Histiocytosis.
- Lung AdenocarcinomaMr. Merlio isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Merlio isExperienced. Learn about Lung Cancer.
- Lymphofollicular HyperplasiaMr. Merlio isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphomatoid PapulosisMr. Merlio isExperienced. Learn about Lymphomatoid Papulosis.
- Marginal Zone Lymphoma (MZL)Mr. Merlio isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- MelanomaMr. Merlio isExperienced. Learn about Melanoma.
- Mycosis FungoidesMr. Merlio isExperienced. Learn about Mycosis Fungoides.
- NecrosisMr. Merlio isExperienced. Learn about Necrosis.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Merlio isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PIK3CA-Related Overgrowth SpectrumMr. Merlio isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Renal Cell Carcinoma (RCC)Mr. Merlio isExperienced. Learn about Renal Cell Carcinoma (RCC).